Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday. The oral drug, branded Symbravo, was approved for the acute treatment of the condition characterized by recurrent attacks of moderate to severe throbbing and pulsating pain on one side of the head.
Axsome secures hard-fought FDA nod for rapid-acting migraine drug Symbravo
Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion Complex (MoSEIC) rapid-absorption technology. It combines with rizatriptan, a 5-HT1B/1D agonist, which was previously sold by Merck as Maxalt before it went generic. Triptans are a first-line class of treatments for migraine.
Symbravo Approved for Acute Treatment of Migraine With or Without Aura
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,
MedPage Today
22h
Acute Migraine Treatment Gets a New Drug
The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...
Medscape
1d
FDA Clears NSAID/Triptan Combo for Migraine in Adults
The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...
7d
Pfizer to pay nearly $60M over kickbacks for migraine drug once promoted by Lady Gaga
The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...
1d
on MSN
Patti Smith blames ‘post-migraine dizziness’ for collapsing onstage in Brazil: ‘Absolutely fine’
Patti Smith will be dancing barefoot again soon. The 78-year-old rocker told her fans she’s “absolutely fine” after she ...
Healio
2d
Migraine tied to higher risk for open-angle glaucoma onset among South Korean adults
A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...
1d
on MSN
Propranolol May reduce ischemic stroke risk alongside preventing Migraine in women: Study
For patients with migraine, the clinical benefits of propranolol, a beta-blocker medication, may extend beyond just migraine ...
2d
Patti Smith Says She's 'Absolutely Fine' After Collapsing Onstage in Brazil amid 'Post-Migraine Dizziness'
Patti Smith collapsed onstage while performing in Brazil on Wednesday, Jan. 29. She later told fans she was "absolutely fine.
7h
Do you know ginger works as a painkiller for migraine and period cramps? Know how to use it
Ginger acts as a wonderful painkiller, very few people know this, but whenever you have severe pain, you can adopt this as a ...
Neurology Advisor
1d
Global Migraine Burden Trends Upward, Increasing Rapidly in Men, Adolescents
The global prevalence and incidence of migraine significantly increased from 1990 to 2021, with faster growth rates predicted in men and adolescents through 2050.
Migraine Again on MSN
22h
Ayurveda and Migraine: Can This Ancient Healing System Help You Manage?
Discover how ayurveda, an ancient healing system, can help you live better with migraine. Discover doshas, dietary strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Patti Smith
Axsome Therapeutics
Brazil
Symbravo
Regine Velasquez
Feedback